Endurance and strength training have different benefits
for people with peripheral arterial disease, but both improve quality of life Synopsis including 3 sets of 8 repetitions of resisted lower limb exercises. External resistance was maintained above 50% of 1 repetition maximum and perceived exertion at 12 to 14. The control group attended 11 sessions that were designed to provide contact with a health professional but not to change behaviour. Outcome measures: The primary outcomes were the change in the six-minute walk test (6MWT) and the short physical performance battery (SPPB) at 6 months. 
Commentary
Previous studies of exercise for PAD have focused on patients with IC. In this study, patients without IC were also included and randomisation was stratified to ensure an even proportion was allocated to each treatment group. This strongly suggests that one premise of this study was to compare the effect of training on PAD patients with IC versus those without IC. The authors report only that these groups had 'reasonably similar' outcomes, stating that the trial was underpowered for this comparison to be made statistically. This may be because fewer than 20% of the participants had IC. Nevertheless, the high proportion of participants without IC provides welcome data about this under-investigated group.
Follow-up for the primary analysis was excellent at 92%. Some secondary outcomes had substantially lower followup, ranging from 56% to 88%. Although this creates a source of error in the results, sensitivity analyses suggest that the missing data were not grossly atypical.
Specificity of training was clearly evident. Treadmill training significantly improved walk-based outcomes, whereas the effects of resistance training were non-significant or lesser. Conversely, only resistance training significantly improved strength-based outcomes. Despite these differences, the size of the effect on quality of life related to physical function was the same for the two regimens.
Clinically worthwhile improvements in six-minute walk distance have not been established in patients with PAD, unlike chronic obstructive pulmonary disease (COPD). The improvement in the treadmill training group of this cohort (20 m), while statistically significant, is less than the improvement considered clinically worthwhile in moderate to severe COPD patients (35 m) (Puhan et al 2008) . As a result, it is difficult to state that the improvement in sixminute walk distance was clinically significant in PAD patients.
The results of this study suggest that clinicians can train patients with PAD and physical limitation, regardless of the presence or absence of symptoms of IC. Furthermore, due to specificity of training, clinicians can prescribe the modality of exercise that more closely targets the specific problems of the individual patient, rather than a 'one modality fits all' approach.
